Gilead beats estimates, raises 2025 guidance, driven by strong HIV and liver drug sales and multiple launches planned for ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Ignore photo claiming to be HIV under microscope - shows caterpillar, not virus!IN SHORT: Viral posts circulating on Facebook in Kenya and Tanzania claim to show HIV magnified under a microscope, ...

Zimbabwe’s donation of ARVs to Botswana sparks mixed reactions online, highlighting regional solidarity and ongoing ...

Nearly 40 years after HIV was first identified, the virus continues its devastating march across the globe. Today, 38 million people live with HIV, and each year brings 1.5 million new infections and ...

Over the course of several months, under President Trump’s Executive Order, federal agencies, including the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and ...

Ministers have been told to review arrangements which currently mean the family of someone who has received infected blood ...

Dzidzai is one of 25 Community Adolescent Treatment Supporters (CATS) trained by the National Aids Council (NAC) and the ...

HOOKIPA Pharma Inc. (OTCID: HOOK, 'HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program and certain of its assets related to HOOKIPA’s HB-500 program ...

NHS Shared Business Services (NHS SBS) has launched an ‘Online Sexual Health Services’ framework agreement designed to help local authorities and NHS healthcare organisations deliver essential sexual ...